Terumo Interventional Systems has announced the launch and commercial availability of its R2P NaviCross peripheral support catheter in the USA as part of the company’s radial-to-peripheral (R2P) portfolio. The Terumo Interventional Systems has announced the launch and commercial availability of its R2P NaviCross peripheral support catheter in the USA as part of the company’s radial-to-peripheral (R2P) portfolio., now available in a 200cm length, is designed for optimized performance in R2P procedures.
“With the 200cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more procedures from a radial approach,” said Michael J. Martinelli, chief medical officer of Terumo Medical Corporation.
“Additionally, the double-braided, stainless-steel design of the R2P NaviCross catheter makes it possible to access and cross simple-to-complex lesions above and below the knee.”
